The Institute for Policy Innovation (IPI) is a free-market policy think tank that focuses on issues related to economic growth, innovation, limited government and individual liberty. Thanks for visiting! Please take a look around and sign up for updates. We welcome your support for our work.
If the president doesn't want to import price-controlled, foreign-made steel, then why does he want to import price-controlled prescription drugs?
Only immediate attention from the White House can prevent WIPO from becoming dominated by China, which would pose risks to the entire global IP system, and thus to U.S. security and innovation.
A step-in-the-right-direction budget—if the reality matches the rhetoric, which it often doesn't.
IPI President Tom Giovanetti files these comments with the SEC encouraging actions to rein in the power of proxy advisory services in protection of individual investors.